Regeneron PharmaceuticalsREGN 
$1,162.002.04%24h
2.04%24h
Global rank111
Market cap$124.48B
Change 7d0.11%
YTD Performance32.97%
SP500 benchmarkOutperform
P/E0
P/S9.49
Revenue$13.12B
Earnings$3.95B
Dividend yield-
Main Sector
Healthcare
EPS for Regeneron Pharmaceuticals (REGN)
Regeneron Pharmaceuticals has an EPS of $38.22. In 2021, the company made an earnings per share (EPS) of $71.97. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for REGN
-
Value:-
EPS history for Regeneron Pharmaceuticals from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2022 | $38.22 | -46.89% |
| 2021 | $71.97 | 135.81% |
| 2020 | $30.52 | - |
View the highest EPS stocks
